Raquel Ferrer‐Oliveras

2.5k total citations
22 papers, 542 citations indexed

About

Raquel Ferrer‐Oliveras is a scholar working on Rheumatology, Hematology and Obstetrics and Gynecology. According to data from OpenAlex, Raquel Ferrer‐Oliveras has authored 22 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 10 papers in Hematology and 7 papers in Obstetrics and Gynecology. Recurrent topics in Raquel Ferrer‐Oliveras's work include Systemic Lupus Erythematosus Research (13 papers), Pregnancy and preeclampsia studies (7 papers) and Reproductive System and Pregnancy (7 papers). Raquel Ferrer‐Oliveras is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), Pregnancy and preeclampsia studies (7 papers) and Reproductive System and Pregnancy (7 papers). Raquel Ferrer‐Oliveras collaborates with scholars based in Spain, France and Italy. Raquel Ferrer‐Oliveras's co-authors include Jaume Alijotas‐Reig, Enrique Esteve‐Valverde, Elisa Llurba, Jean‐Christophe Gris, L. Cabero, Miquel Vilardell‐Tarrés, Manel Mendoza, E. Carreras, Pablo García‐Manau and Inmaculada Farrán-Codina and has published in prestigious journals such as Annals of the Rheumatic Diseases, Fertility and Sterility and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

Raquel Ferrer‐Oliveras

21 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raquel Ferrer‐Oliveras Spain 13 237 199 193 130 121 22 542
Angela Botta Italy 14 158 0.7× 482 2.4× 179 0.9× 211 1.6× 144 1.2× 27 690
H Carp Israel 17 248 1.0× 124 0.6× 405 2.1× 199 1.5× 241 2.0× 22 745
Amélie Benbara France 13 290 1.2× 172 0.9× 44 0.2× 84 0.6× 74 0.6× 36 529
Neil Pattison New Zealand 9 172 0.7× 201 1.0× 78 0.4× 200 1.5× 67 0.6× 12 521
Serafina Garofalo Italy 11 130 0.5× 100 0.5× 80 0.4× 46 0.4× 72 0.6× 26 357
Nilson Ramires de Jesús Brazil 11 123 0.5× 392 2.0× 245 1.3× 48 0.4× 287 2.4× 28 607
Marie Bornes France 13 191 0.8× 71 0.4× 250 1.3× 52 0.4× 169 1.4× 27 532
S. P. Kaandorp Netherlands 7 401 1.7× 76 0.4× 354 1.8× 369 2.8× 274 2.3× 9 838
R.M. Silver United States 10 144 0.6× 208 1.0× 74 0.4× 157 1.2× 103 0.9× 27 496
Bruce B. Feinberg United States 14 400 1.7× 29 0.1× 390 2.0× 89 0.7× 99 0.8× 24 638

Countries citing papers authored by Raquel Ferrer‐Oliveras

Since Specialization
Citations

This map shows the geographic impact of Raquel Ferrer‐Oliveras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Ferrer‐Oliveras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Ferrer‐Oliveras more than expected).

Fields of papers citing papers by Raquel Ferrer‐Oliveras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquel Ferrer‐Oliveras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Ferrer‐Oliveras. The network helps show where Raquel Ferrer‐Oliveras may publish in the future.

Co-authorship network of co-authors of Raquel Ferrer‐Oliveras

This figure shows the co-authorship network connecting the top 25 collaborators of Raquel Ferrer‐Oliveras. A scholar is included among the top collaborators of Raquel Ferrer‐Oliveras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquel Ferrer‐Oliveras. Raquel Ferrer‐Oliveras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mendoza, Manel, et al.. (2022). Angiogenic factors for planning fetal surveillance in fetal growth restriction and small‐for‐gestational‐age fetuses: A prospective observational study. BJOG An International Journal of Obstetrics & Gynaecology. 129(11). 1870–1877. 18 indexed citations
2.
García‐Manau, Pablo, et al.. (2022). sFlt-1 to PlGF ratio cut-offs to predict adverse pregnancy outcomes in early-onset FGR and SGA: a prospective observational study. Journal of Obstetrics and Gynaecology. 42(7). 2840–2845. 11 indexed citations
3.
Ferrer‐Oliveras, Raquel, Manel Mendoza, Laia Pratcorona, et al.. (2021). Immunological and physiopathological approach of COVID-19 in pregnancy. Archives of Gynecology and Obstetrics. 304(1). 39–57. 25 indexed citations
4.
Carreras, E., Jaume Alijotas‐Reig, Manel Mendoza, et al.. (2020). Evaluating the Effect of Pravastatin in Early-Onset Fetal Growth Restriction: A Nonrandomized and Historically Controlled Pilot Study. American Journal of Perinatology. 38(14). 1472–1479. 18 indexed citations
5.
Esteve‐Valverde, Enrique, Jaume Alijotas‐Reig, Raquel Ferrer‐Oliveras, et al.. (2019). AB0165 THE EUROPEAN REGISTRY ON OBSTETRIC ANTIPHOSPHOLIPID SYNDROME (EUROAPS): A SURVEY OF 1100 CONSECUTIVE CASES. Annals of the Rheumatic Diseases. 78. 1541–1541. 7 indexed citations
6.
Esteve‐Valverde, Enrique, et al.. (2018). Pravastatin for Preventing and Treating Preeclampsia: A Systematic Review. Obstetrical & Gynecological Survey. 73(1). 40–55. 48 indexed citations
7.
Alijotas‐Reig, Jaume, Enrique Esteve‐Valverde, Raquel Ferrer‐Oliveras, et al.. (2018). Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies. Medicina Clínica (English Edition). 151(6). 215–222. 2 indexed citations
8.
Mékinian, A., Jaume Alijotas‐Reig, Fabrice Carrat, et al.. (2017). Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study. Autoimmunity Reviews. 16(7). 730–734. 46 indexed citations
9.
Alijotas‐Reig, Jaume, Enrique Esteve‐Valverde, Raquel Ferrer‐Oliveras, Elisa Llurba, & Jean‐Christophe Gris. (2017). Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review. Clinical Reviews in Allergy & Immunology. 53(1). 40–53. 171 indexed citations
10.
Alijotas‐Reig, Jaume, Enrique Esteve‐Valverde, Raquel Ferrer‐Oliveras, et al.. (2017). Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies. Medicina Clínica. 151(6). 215–222. 20 indexed citations
11.
Alijotas‐Reig, Jaume, Enrique Esteve‐Valverde, & Raquel Ferrer‐Oliveras. (2016). Tratamiento de las gestantes con enfermedades reumáticas o autoinmunitarias sistémicas con fármacos inmunodepresores y biológicos. Medicina Clínica. 147(8). 352–360. 7 indexed citations
12.
Alijotas‐Reig, Jaume, Enrique Esteve‐Valverde, & Raquel Ferrer‐Oliveras. (2016). Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease. Medicina Clínica (English Edition). 147(8). 352–360. 7 indexed citations
13.
Alijotas‐Reig, Jaume, Raquel Ferrer‐Oliveras, Enrique Esteve‐Valverde, et al.. (2016). Inherited thrombophilia in women with poor aPL‐related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort. American Journal of Reproductive Immunology. 76(2). 164–171. 9 indexed citations
14.
Esteve‐Valverde, Enrique, Raquel Ferrer‐Oliveras, & Jaume Alijotas‐Reig. (2015). Síndrome antifosfolipídico obstétrico. Revista Clínica Española. 216(3). 135–145. 15 indexed citations
15.
Alijotas‐Reig, Jaume & Raquel Ferrer‐Oliveras. (2012). The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A preliminary first year report. Lupus. 21(7). 766–768. 36 indexed citations
16.
Ferrer‐Oliveras, Raquel, Elisa Llurba, L. Cabero, & Jaume Alijotas‐Reig. (2011). Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets. Lupus. 21(3). 257–263. 18 indexed citations
17.
Alijotas‐Reig, Jaume, et al.. (2009). Anti-annexin A5 antibodies in women with spontaneous pregnancy loss. Medicina Clínica. 134(10). 433–438. 14 indexed citations
18.
Alijotas‐Reig, Jaume, et al.. (2009). Anti-β2-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss. Fertility and Sterility. 93(7). 2330–2336. 26 indexed citations
19.
Alijotas‐Reig, Jaume, et al.. (2008). Recurrent Kikuchi–Fujimoto disease during pregnancy: Report of case evolving into systemic lupus erythematosus and review of published work. Journal of obstetrics and gynaecology research. 34(4pt2). 595–598. 12 indexed citations
20.
Alijotas‐Reig, Jaume, et al.. (2008). ORIGINAL ARTICLE: Are Anti‐Beta2‐Glycoprotein‐I Antibodies Markers for Recurrent Pregnancy Loss in Lupus Anticoagulant/Anticardiolipin Seronegative Women?. American Journal of Reproductive Immunology. 60(3). 229–237. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026